News

The goal of the joint projects with the National University of Singapore (NUS) is to profile oncology drugs in Asian populations, to identify novel biomarkers and to investigate

The company has recently filed a US patent application covering its collection of novel proteins and genes that are specifically expressed in colorectal cancer cells. Partial funding for

The Daiichi Sankyo Group currently possesses four pharmaceutical formulation plants in Japan. The Osaka plant will be closed after comprehensive evaluation of the current product line, overseas market

The laboratory will accommodate more than 100 employees focused on the discovery of important new molecules to treat serious diseases, the company said. Steven Gilman, chief scientific officer

Prior to Noven, Mr Amanatides served DSM Pharmaceuticals in several senior quality roles. Most recently, Mr Amanatides has served as senior director of quality operations and regulatory affairs,

This five-year contract was awarded by the National Institutes of Health’s (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to develop novel vaccine adjuvant candidates that signal

The new name builds on an already strong European position as a contract research and manufacturing organization specialized in the development of recombinant biotherapeutics, the company said. Tristan

Mr Lim and Mr Wan are both independent directors and will serve on the audit committee, the compensation committee, and the corporate governance and nominating committees. Mr Wan

The restructuring program, which includes projects in all four business segments and at corporate, will result in the company incurring pre-tax charges of approximately $200 million beginning in